Sulfasalazine or enteral diets containing fish oil or oligosaccharides attenuate chronic colitis in rats

Inflammatory Bowel Diseases

Volumn 2, Issue 3, 1996, Pages 178-188

  Grisham, Matthew B ^a   DeMichele, Stephen J ^b   Garleb, Keith A ^b   Specian, Robert D ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Chronic colitis; Enteral diets; Fish oil; Oligosaccharides; Rat study; Sulfasalazine

Indexed keywords

EID: 0000642926     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1002/ibd.3780020305     Document Type: Article

References (57)

1. Empey LR, Jewell LD, Garg ML, Thomson ABR, Clandenen MT, Fedorak RN. Fish oil-enriched diet is mucosal protective against acetic acid-induced colitis in rats. Can J Physiol Pharmacol 1991;69:480-7.
2. Vilaseca J, Salas A, Guarner F, Rodriguez R, Martinez M, Malagelada JR. Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut 1990;31:534-9.
3. Schepp W, Peskar BM, Trautmann M, Stoite M, HagenMuller F, Schusdziarra V, Classen M. Fish oil reduces ethanol-induced damage of the duodenal mucosa in humans. Gastroenterology 1989;96:446.
4. Lorenz R, Weber PC, Szimnan P, Heldwein W, Strasser T, Loeschke K. Supplementation with N-3 fatty acids from fish oil in chronic inflammatory bowel disease. J Int Med Suppl 1989;225:225-32.
5. Hillier K, Jewell R, Dorrell L, Smith CL. Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease. Gut 1991;32:1151-5.
6. Saloman P, Kornbluth AA, Janowitz MD. Treatment of ulcerative colitis with fish oil N-3-w-fatty acid: an open trial. J Clin Gastroenterol 1990;12:157-61.
7. Fretland DJ, Djuric SW, Gaginella TS. Eicosanoids and inflammatory bowel disease: regulation and prospects for therapy. Prostaglandins Leukot Essent Fatty Acids 1990;41:215-33.
8. Breuer RI, Buto S, Christ ML, Bean J, Vernia P, Paoluzi P, DiPaolo MC, Caprilli R. Rectal irrigation with short-chain fatty acids for distal ulcerative colitis [Preliminary report]. Dig Dis Sci 1991;36:185-7.
9. Senagore AJ, MacKeigan JM, Scheider M, Ebrom JS. Short-chain fatty acid enemas: a cost effective alternative in the treatment of nonspecific proctosigmoiditis. Dis Colon Rectum 1992;35:923.
10. Hang JM, Soergel KH, Komorowski RA, Wood CM. Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med 1989;310:23-8.
11. Smith CS, Bryant MP. Introduction to metabolic activities of intestinal bacteria. Am J Clin Nutr 1979;32:149-57.
12. Miller T, Wolin M. Fermentation by saccharolytic intestinal bacteria. Am J Clin Nutr 1979;32:164-72.
13. Cummings JH. Fermentation in the human large intestine: evidence and implications for health. Lancet 1983;1:1206-9.
14. Titgemeyer EC, Bourquin LD, Fahey GC Jr, Garleb KA. Fermentability of various fiber sources by human fecal bacteria in vitro. Am J Clin Nutr 1991;53:1418-24.
15. Salyers A, Vercellotti J, West S, Wilkin T. Fermentation of mucin and plant polysaccharides by strains of bacteroides from the human colon. Appl Environ Microbiol 1977;33:319-22.
16. Mitsuoka T, Hidaka H, Eida T. Effect of fructo-oligosaccharides on intestinal microflora. Nahrung 1987;31:427-36.
17. Tokunaga T, Oku T, Hosoya N. Influence of chronic intake of a new sweetener fructooligosaccharide (Neosugar) on growth and gastrointestinal function of the rat. J Nutr Sci Vitaminol (Tokyo) 1986;32:111-21.
18. Yamada T, Sartor RB, Marshall S, Specian RD, Grisham MB. Mucosal injury and inflammation in a model of granulomatous colitis in rats. Gastroenterology 1993;104:759-77.
19. Grisham MB, Specian RD, Zimmerman TE. Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. J Pharmacol Exp Ther 1994;271:1114-21.
20. Yamada T, Volkmer C, Grisham MB. Antioxidant properties of 5-ASA: potential mechanisms for its anti-inflammatory activity. Can J Gastroenterol 1990;4:1-8.
21. Sharon P, Ligumsky M, Rachmilewitz D, Zor U. Role of prostaglandins in ulcerative colitis: Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology 1978;75:638-40.
22. 2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine. Gastroenterology 1981;81:444-9.
23. 4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 1984;86:453-60.
24. Lauritsen K, Laursen IS, Bukhave K, Rask-Madsen J. In vivo effects of orally administered prednisolone on prostaglandin and leukotriene production in ulcerative colitis. Gut 1987;28:1095-9.
25. Lauritsen K, Laursen IS, Bukhave K, Rask-Madsen J. In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis and Clostridium difficile colitis. Gastroenterology 1988;95:11-7.
26. Seidman EG. Nutritional management of inflammatory bowel disease. Gastroenterol Clin North Am 1989;17:129-55.
27. Dudrick SJ, Latifi R, Schrager R. Nutritional management of inflammatory bowel disease. Surg Clin North Am 1991;71: 609-23.
28. Teahon K, Bjarnason I, Levi AJ. The role of enteral and parenteral nutrition in Crohn's disease and ulcerative colitis. Prog Inflam Bowel Dis 1991;12:1-4.
29. Vilaseca J, Salas A, Guarner F, Rodriguez R, Malagelada JR. Participation of thromboxane and other eicosanoid synthesis in the course of experimental inflammatory colitis. Gastroenterology 1990;98:269-77.
30. Donowitz M. Arachidonic acid metabolites and their role in inflammatory bowel disease: an update requiring addition of a pathway. Gastroenterology 1985;88:580-7.
31. Musch MW, Miller RJ, Field M, Siegel MI. Stimulation of colonie secretion by lipoxygenase metabolites of arachidonic acid. Science 1982;17:1255-6.
32. Palmer RM, Stepney R, Higgs GA, Eakins KE. Chemokinetic activity of arachidonic acid lipoxygenase products on leukocytes from different species. Prostaglandins 1980;20: 411-48.
33. Stenson WF, Parker CW. Monohydroxyeicosatetraenoic acids (HETE's) induce degranulation of human neutrophils. J Immunol 1980;124:2100-4.
34. Janne P, Carpentier Y, Willems G. Colonie mucosal atrophy induced by a liquid elemental diet in rats. Dig Dis 1977;22: 808-12.
35. Morin C, Ling V, Bourassa D. Small intestinal and colonie changes induced by a chemically defined diet. Dig Dis Sci 1980;25:123-8.
36. Sircar B, Johnson LR, Lichtenberger LM. Effect of synthetic diets on gastrointestinal mucosal DNS synthesis in rats. Am J Physiol 1983;244:G327-35.
37. Ryan GP, Dudrick SJ, Copeland EM, Johnson LR. Effects of various diets on colonie growth in rats. Gastroenterology 1979;77:658-63.
38. Storme G, Willems G. The effects of a liquid elemental diet on cell proliferation in the colon of rats. Cell Tissue Res 1981;216:221-5.
39. Goodlad RA, Lenton W, Ghatei MA, Adrian TE, Bloom SR. Proliferation effects of fibre on the intestinal epithelium. Gut 1987;28:221-6.
40. Kripe SA, Fox AD, Berman JM, Settle RG, Rombeau JL. Stimulation of intestinal mucosal growth with intracolonic infusion of short-chain fatty acids. J Parenter Enter Nutr 1989;13:109-16.
41. Scheppach W, Bartram P, Richter A, Richter F, Liepold H, Dusel G, Hofstetter G, Ruthlein J, Kasper H. Effect of short-chain-fatty acids on the human colonic mucosa in vitro. J Parenter Enter Nutr 1992;16:43-8.
42. Sakata T. Stimulatory effect of short-chain fatty acids on epithelial cell proliferation in the rat intestine: a possible explanation for trophic effects on fermentable fibre: gut microbes and luminal trophic factors. Br J Nutr 1987;58:95-103.
43. Thomas MG, Owen RW, Alexander B, Williamson RC. Effect of enteral feeding on intestinal epithelial proliferation and fecal bile acid profiles in the rat. J Parenter Enter Nutr 1993;17:210-3.
44. Rolandelli RH, Saul SH, Settle RG, Jacobs DO, Trerotola SO, Rombeau JL. Comparison of parenteral nutrition and enteral feeding with pectin in experimental colitis in the rat Am J Clin Nutr 1988;47:15-21.
45. Imaizumi K, Nakatsu Y, Sato M, et al. Effects of xylooligosaccharides on blood glucose, serum and liver lipids and cecum short-chain fatty acids in diabetic rats. Agric Biol Chem 1991;55:199-205.
46. Hidaka H. Fructooligosaccharides, a newly developed food material for health. Kagaku To Seibutsu 1983;21:291-3.
47. Hidaka H, Hirayama M, Sumi N. A fructooligosaccharide-producing enzyme from Aspergillus niger ATCC 20611. Agric Biol Chem 1988;52:1181-7.
48. Clevenger MA, Turnbull D, Inoue H, et al. Toxicological evaluation of Neosugar: genotoxicity, carcinogenicity, and chronic toxicity. J Am Coll Toxicol 1988;7:643-62.
49. Spiegel JE, Rose R, Karabell P, et al. Safety and benefits of fructooligosaccharides as food ingredients. Food Technol 1994;48:85-9.
50. Wolf BW, et al. Fermentability of selected oligosaccharides. FASEB J 1994;8:A186.
51. Mitsuoka T, Kaneuchi C. Ecology of bifidobacteria. Am J Clin Nutr 1977;30:1799-810.
52. Rasic JL. The role of dairy food containing bifido- and acidophil bacteria in nutrition and health. N Eur Dairy J 1983; 48:80-8.
53. Ishibashi N, Shimamura S. Bifidobacteria: research and development in Japan. Food Technol 1993;June:126-35.
54. Ballongue J. Bifidobacteria and probiotic action. In Hentges D, ed. Human intestinal flora in health and disease. New York: Academic Press, 1983:357-428.
55. Wang X, Gibson GR. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol 1993;75:373-80.
56. Williams CH, Witherly SA, Buddington RK. Influence of dietary Neosugar on selected bacterial groups of the human faecal microbiota. Microbial Ecol Health Dis 1994;7:91-7.
57. Mitsuoka T, Hidaka H, Eida T. Effect of fructooligosaccharides on intestinal microflora. Die Nahrung 1987;31: 427-36.